ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
The imbalance in the availability of vaccines and supply shortages may worsen without international cooperation for smooth distribution. (Source photo by Reuters)
Datawatch

Supply imbalance leaves 150m doses of COVID vaccine unused

Makers scramble to meet demand; situation may worsen if booster shots needed

MIO TOMITA, RYOSUKE HANADA and KOTARO HOSOKAWA, Nikkei staff writers | U.S.

TOKYO/SEOUL -- Imbalance in COVID-19 vaccine supply is deepening around the world. The U.S., EU and other nations that produce and export vaccines have surpluses totaling more than 150 million doses, while shortages have caused delays in vaccination in many countries in Asia. 

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more